Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1917 1
1930 1
1932 1
1935 1
1937 1
1940 1
1941 1
1946 4
1947 1
1948 1
1949 1
1950 4
1951 1
1952 1
1954 1
1956 3
1957 5
1958 5
1959 4
1960 11
1961 3
1962 17
1963 14
1964 6
1965 15
1966 9
1967 14
1968 12
1969 10
1970 22
1971 16
1972 27
1973 28
1974 18
1975 19
1976 30
1977 21
1978 22
1979 19
1980 29
1981 33
1982 35
1983 29
1984 28
1985 41
1986 37
1987 52
1988 43
1989 45
1990 41
1991 48
1992 36
1993 51
1994 49
1995 50
1996 28
1997 46
1998 44
1999 52
2000 48
2001 44
2002 45
2003 29
2004 59
2005 50
2006 81
2007 80
2008 88
2009 90
2010 96
2011 91
2012 101
2013 129
2014 128
2015 151
2016 163
2017 136
2018 153
2019 151
2020 148
2021 170
2022 156
2023 146
2024 118
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,488 results

Results by year

Filters applied: . Clear all
Page 1
Selective Inhibition of NaV1.8 with VX-548 for Acute Pain.
Jones J, Correll DJ, Lechner SM, Jazic I, Miao X, Shaw D, Simard C, Osteen JD, Hare B, Beaton A, Bertoch T, Buvanendran A, Habib AS, Pizzi LJ, Pollak RA, Weiner SG, Bozic C, Negulescu P, White PF; VX21-548-101 and VX21-548-102 Trial Groups. Jones J, et al. Among authors: shaw d. N Engl J Med. 2023 Aug 3;389(5):393-405. doi: 10.1056/NEJMoa2209870. N Engl J Med. 2023. PMID: 37530822 Clinical Trial.
Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia.
Varkaris A, Pazolli E, Gunaydin H, Wang Q, Pierce L, Boezio AA, Bulku A, DiPietro L, Fridrich C, Frost A, Giordanetto F, Hamilton EP, Harris K, Holliday M, Hunter TL, Iskandar A, Ji Y, Larivée A, LaRochelle JR, Lescarbeau A, Llambi F, Lormil B, Mader MM, Mar BG, Martin I, McLean TH, Michelsen K, Pechersky Y, Puente-Poushnejad E, Raynor K, Rogala D, Samadani R, Schram AM, Shortsleeves K, Swaminathan S, Tajmir S, Tan G, Tang Y, Valverde R, Wehrenberg B, Wilbur J, Williams BR, Zeng H, Zhang H, Walters WP, Wolf BB, Shaw DE, Bergstrom DA, Watters J, Fraser JS, Fortin PD, Kipp DR. Varkaris A, et al. Among authors: shaw de. Cancer Discov. 2024 Feb 8;14(2):240-257. doi: 10.1158/2159-8290.CD-23-0944. Cancer Discov. 2024. PMID: 37916956 Free PMC article.
Pub Philosophy.
Shaw D. Shaw D. J Bioeth Inq. 2019 Mar;16(1):7-12. doi: 10.1007/s11673-019-09896-3. J Bioeth Inq. 2019. PMID: 30680613 No abstract available.
Ethics of ECPR research.
Suverein MM, Shaw D, Lorusso R, Delnoij TSR, Essers B, Weerwind PW, Townend D, van de Poll MCG, Maessen JG. Suverein MM, et al. Among authors: shaw d. Resuscitation. 2021 Dec;169:136-142. doi: 10.1016/j.resuscitation.2021.08.007. Epub 2021 Aug 17. Resuscitation. 2021. PMID: 34411691 Free article. Review.
GATA4 controls regionalization of tissue immunity and commensal-driven immunopathology.
Earley ZM, Lisicka W, Sifakis JJ, Aguirre-Gamboa R, Kowalczyk A, Barlow JT, Shaw DG, Discepolo V, Tan IL, Gona S, Ernest JD, Matzinger P, Barreiro LB, Morgun A, Bendelac A, Ismagilov RF, Shulzhenko N, Riesenfeld SJ, Jabri B. Earley ZM, et al. Among authors: shaw dg. Immunity. 2023 Jan 10;56(1):43-57.e10. doi: 10.1016/j.immuni.2022.12.009. Immunity. 2023. PMID: 36630917 Free PMC article.
Re-focusing explainability in medicine.
Arbelaez Ossa L, Starke G, Lorenzini G, Vogt JE, Shaw DM, Elger BS. Arbelaez Ossa L, et al. Among authors: shaw dm. Digit Health. 2022 Feb 11;8:20552076221074488. doi: 10.1177/20552076221074488. eCollection 2022 Jan-Dec. Digit Health. 2022. PMID: 35173981 Free PMC article. Review.
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.
Grebely J, Dalgard O, Conway B, Cunningham EB, Bruggmann P, Hajarizadeh B, Amin J, Bruneau J, Hellard M, Litwin AH, Marks P, Quiene S, Siriragavan S, Applegate TL, Swan T, Byrne J, Lacalamita M, Dunlop A, Matthews GV, Powis J, Shaw D, Thurnheer MC, Weltman M, Kronborg I, Cooper C, Feld JJ, Fraser C, Dillon JF, Read P, Gane E, Dore GJ; SIMPLIFY Study Group. Grebely J, et al. Among authors: shaw d. Lancet Gastroenterol Hepatol. 2018 Mar;3(3):153-161. doi: 10.1016/S2468-1253(17)30404-1. Epub 2018 Jan 6. Lancet Gastroenterol Hepatol. 2018. PMID: 29310928 Free article. Clinical Trial.
Intergenerational global heath.
Shaw DM, Rich LE. Shaw DM, et al. J Bioeth Inq. 2015 Mar;12(1):1-4. doi: 10.1007/s11673-015-9629-5. Epub 2015 Feb 25. J Bioeth Inq. 2015. PMID: 25711209 No abstract available.
3,488 results